Evidence map›Paper›PMID 38025518›Full record

ReviewVascular health and risk management2023

Vascular Health Promotion Project and Vascular Medicine in China-CCVM2004-2023.

Fang Wen, Shantong Jiang, Ping Yuan, Jinbo Liu, Xiu Bai, Hongwei Zhao, Xin Chen, Yan-Bing Gong, Roland Asmar, Hongyu Wang

Abstract readReview
In one paragraph

Review in Vascular health and risk management, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fang Wen *Department of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.ORCID 0000-0001-9660-2927
Shantong Jiang *Department of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.ORCID 0009-0006-3245-8800
Ping Yuan *Department of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.ORCID 0000-0002-0888-6059
Jinbo LiuDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.ORCID 0000-0003-1297-2176
Xiu BaiDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.ORCID 0009-0009-6902-4354
Hongwei ZhaoDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.
Xin ChenDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.
Yan-Bing GongDepartment of Scientific Research, Peking University Shougang Hospital, Beijing, People's Republic of China.ORCID 0000-0001-8896-3765
Roland AsmarFoundation-Medical Research Institutes, Beirut, Lebanon.ORCID 0000-0002-5676-3491
Hongyu WangDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, People's Republic of China.ORCID 0000-0003-1869-7718

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease(CVD) has become a major disease burden affecting people's health in China. Blood vessels are very important for human health and are the "sentinel" for the development of many cardiovascular and cerebrovascular diseases. The key to effectively preventing fatal, disabling heart, brain and peripheral vascular events lies in controlling traditional and non-traditional risk factors for vascular health from the source, and early assessment and intervention of early vascular lesions. Since 2004, China government promoted the early detection technology of vascular lesions and vascular medicine, and proposed the Beijing Vascular Health Stratification (BVHS) to provide suggestions for the examination, evaluation and management of risk factors, and to provide new ideas for lifelong maintenance of vascular health. This review mainly introduces the establishment and development of the clinical discipline of "vascular medicine" in the past 20 years in China, introduces the indicators for detecting vascular function and structure and the predictive value of vascular events, and carries out intelligent and digital management of vascular health throughout the life cycle of individualized prevention, treatment and rehabilitation for people with different parts or degrees of lesions, effectively reducing the occurrence and development of cardiovascular and cerebrovascular diseases, and the prospect of new technology in maintaining vascular health.

Indexed as

CardiologyCardiovascular DiseasesCerebrovascular DisordersChinaHealth PromotionHumansRisk FactorsBeijing vascular health stratificationdigitalearly assessmentheart and vascular healthvascular medicine

Identifiers

PMID38025518
PMCPMC10656854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.